Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-α with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus

被引:56
作者
Lu, Lin
Pu, Li Jin
Xu, Xue Wei
Zhang, Qi
Zhang, Rui Yan
Zhang, Jian Sheng
Hu, Jian
Yang, Zheng Kun
Lu, An Kang
Ding, Feng Hua
Shen, Jie
Chen, Qiu Jin
Lou, Sheng
Fang, Dan Hong
Shen, Wei Feng
机构
[1] Jiao Tong Univ, Dept Cardiol, Sch Med, Rui Jin Hosp, Shanghai 200025, Peoples R China
[2] Jiao Tong Univ, Sch Med, Inst Cardiovasc Dis, Shanghai 200025, Peoples R China
关键词
glycated albumin; HbAlc; C-reactive protein; tumor necrosis factor-a; type 2 diabetes mellitus; INFLAMMATORY MARKERS; AMADORI-ALBUMIN; END-PRODUCTS; NEPHROPATHY; ATHEROSCLEROSIS; LOCALIZATION; ACTIVATION; EXPRESSION; BLOCKADE; RISK;
D O I
10.1016/j.clinbiochem.2007.03.022
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: This study aimed to determine whether elevated serum levels of glycated albumin, high-sensitivity C-reactive protein (hsCRP) and tumor necrosis factor (TNF)-alpha were related to an increased risk for coronary artery disease (CAD) and renal insufficiency in patients with type 2 diabetes mellitus (T2DM). Design and methods: Serum levels of glycated albumin, hsCRP, TNF-alpha and blood glycosylated hemoglobin A1c (HbA1c) were measured in 317 consecutive patients with T2DM and 309 normal controls. Patients with T2DM were grouped based upon coronary angiographic findings (Group I: 151 patients with normal coronary arteries; Group II: 166 patients with significant coronary stenosis [> 70% luminal diameter narrowing]) and renal functional status evaluated by estimated creatinine clearance (CrCl) (normal renal function group: 187 patients with CrCl > 90 mL/min; mild renal insufficiency group: 103 patients with CrCl 60-90 mL/min; moderate renal insufficiency group: 27 patients with CrCl 30-60 mL/min). Multivariate analysis was performed to determine independent risk factors for CAD and renal insufficiency in patients with T2DM. Results: Serum levels of glycated albumin, hsCRP and TNF-a were significantly higher in Group II than in controls (P < 0.01) and Group I (P < 0.01). A significant difference was found in glycated albumin, hsCRP and TNF-alpha levels among diabetic patients with mild, moderate renal insufficiency and normal renal function (P < 0.05). These biochemical measurements correlated significantly with number of diseased coronary vessels (P0.01) and status of renal function (P < 0.05). No difference existed in HbA1c levels between Group II and Group I, and among patients with various CrCL stages. Multivariate analysis revealed that male gender, old age and serum levels of glycated albumin, hsCRP, TNF-alpha and lipoprotein (a) were independent risk factors for CAD, and older age, hypertension and glycated albumin were for CrCl < 60 mL/mm in diabetes. Conclusions: Increased serum levels of glycated albumin, hsCRP and TNF-alpha are associated with the presence and severity of CAD and renal impairment in patients with T2DM. (c) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:810 / 816
页数:7
相关论文
共 34 条
  • [1] Advanced glycation endproducts - role in pathology of diabetic complications
    Ahmed, N
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) : 3 - 21
  • [2] Glycated human serum albumin induces IL-8 and MCP-1 gene expression in human corneal keratocytes
    Bian, ZM
    Elner, VM
    Lukacs, NW
    Strieter, RM
    Kunkel, SL
    Elner, SG
    [J]. CURRENT EYE RESEARCH, 1998, 17 (01) : 65 - 72
  • [3] Biochemistry and molecular cell biology of diabetic complications
    Brownlee, M
    [J]. NATURE, 2001, 414 (6865) : 813 - 820
  • [4] RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice
    Bucciarelli, LG
    Wendt, T
    Qu, W
    Lu, Y
    Lalla, E
    Rong, LL
    Goova, MT
    Moser, B
    Kislinger, T
    Lee, DC
    Kashyap, Y
    Stern, DM
    Schmidt, AM
    [J]. CIRCULATION, 2002, 106 (22) : 2827 - 2835
  • [5] GLYCOSYLATION OF HEMOGLOBIN - RELEVANCE TO DIABETES-MELLITUS
    BUNN, HF
    GABBAY, KH
    GALLOP, PM
    [J]. SCIENCE, 1978, 200 (4337) : 21 - 27
  • [6] Potential cardiovascular risk factors in chronic kidney disease:: AGEs, total homocysteine and metabolites, and the C-reactive protein
    Busch, M
    Franke, S
    Müller, A
    Wolf, M
    Gerth, J
    Ott, U
    Niwa, T
    Stein, G
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (01) : 338 - 347
  • [7] Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study
    Cesari, M
    Penninx, BWJH
    Newman, AB
    Kritchevsky, SB
    Nicklas, BJ
    Sutton-Tyrrell, K
    Rubin, SM
    Ding, JZ
    Simonsick, EM
    Harris, TB
    Pahor, M
    [J]. CIRCULATION, 2003, 108 (19) : 2317 - 2322
  • [8] Indicators for blood glucose control in diabetics with end - stage chronic renal disease : GHb vs. glycated albumin (GA)
    Chujo, Keiko
    Shima, Kenji
    Tada, Hiroaki
    Oohashi, Teruyo
    Minakuchi, Jun
    Kawashima, Syu
    [J]. JOURNAL OF MEDICAL INVESTIGATION, 2006, 53 (3-4) : 223 - 228
  • [9] Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency
    Cohen, Margo P.
    Lautenslager, Gregory T.
    Hud, Elizabeth
    Shea, Elizabeth
    Wang, Amy
    Chen, Sheldon
    Shearman, Clyde W.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (02) : F789 - F795
  • [10] Intervention strategies to prevent pathogenetic effects of glycated albumin
    Cohen, MP
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 419 (01) : 25 - 30